Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression
- 1 July 2003
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 39 (1), 112-114
- https://doi.org/10.1016/s0168-8278(03)00243-5
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisitedHepatology, 2002
- The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosisHepatology, 2000
- Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trialJournal of Hepatology, 2000
- Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosisHepatology, 1999
- Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosisGastroenterology, 1997
- Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosisGastroenterology, 1996
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosisGastroenterology, 1994
- The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosisHepatology, 1994
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisThe New England Journal of Medicine, 1991
- Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trialGastroenterology, 1989